| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | | Total Revenue | 5 | 442 | | Cost of Revenue |
-
|
-
| | | Gross Profit | 5 | 442 | | | Operating Expenses | | Research Development |
-
|
-
| | Selling General and Administrative | 1,087 | 999 | | Non Recurring | 140 |
-
| | Others |
-
|
-
| | | | Total Operating Expenses |
-
|
-
| | | | Operating Income or Loss | (1,222) | (557) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 21 | 27 | | Earnings Before Interest And Taxes | (1,201) | (531) | | Interest Expense | 4 | 2 | | Income Before Tax | (1,205) | (532) | | Income Tax Expense |
-
| 6 | | Minority Interest |
-
| (1) | | | | Net Income From Continuing Ops | (1,205) | (540) | | | Non-recurring Events | | Discontinued Operations | (28) |
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | (1,233) | (540) | | Preferred Stock And Other Adjustments |
-
|
-
| | | Net Income Applicable To Common Shares | ($1,233) | ($540) |
|
0.20% Nasdaq 
Income Statement
